Clinical Trial

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction

Dimensions: NCT02341534

Affiliations

Organisations

  1. (1) Rigshospitalet, grid.475435.4, Capital Region
  2. (2) Aalborg Hospital, grid.27530.33, North Denmark Region

Sponsors/collaborators

Countries

Denmark

Continents

Europe

Abstract

The BIO|GUARD-MI study investigates whether continuous arrhythmia monitoring and the consequent treatment after detected arrhythmias in patients after myocardial infarction with preserved cardiac function, but other risk factors, decreases the risk of major adverse cardiac events. Detailed Description Patients randomized to the BioMonitor arm will receive an implantable cardiac monitor (ICM; BioMonitor) with remote monitoring function (Home Monitoring®). If the device detects and reports an arrhythmia, patients will be appropriately examined and treated. Patients randomized to the control arm will receive best proven treatment, but no implantable cardiac monitor.

Methods

Condition: Myocardial Infarction

Intervention: Patients will be implanted with the BioMonitor + standard of care

Recruitment information

Gender: All

Trial period

2015-2022

Research Categories

Main Subject Area

Fields of Research

External sources

Access at Registry